Bio-Synthesis Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Bio-Synthesis

Access the complete profile.

Bio-Synthesis Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325414 Biological Product Manufacturing
Additional NAICS Codes	54138 Testing Laboratories 5417 Scientific Research & Development Services
Address	800 Mario Ct Lewisville, TX 75057

Note: Revenues for privately held companies are statistical evaluations.


Bio-Synthesis's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bio-Synthesis's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Bio-Synthesis is classified as operating in the Biological Product Manufacturing industry, NAICS Code 325414.

Bio-Synthesis Annual Revenue and Growth Rate

Bio-Synthesis	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bio-Synthesis's revenues are gauged from an analysis of company filings.

Bio-Synthesis's Income Statement (based on Industry Averages)

Bio-Synthesis P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Bio-Synthesis is developing and marketing. Bio-Synthesis doesn't have any recent trademark applications, indicating Bio-Synthesis is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
UBERGENE A synthetic oligonucleotide for scientific or research use	05/07/2010
DNAEXAM DNA sample collection swab kit consisting of buccal swabs, sterile cotton-tipped applicators with plastic shafts, color coded paper sample envelopes and authorization forms sold as a unit	10/23/2008
DNA EXAM DNA sample collection swab kit consisting of buccal swabs, sterile cotton-tipped applicators with plastic shafts, color coded paper sample envelopes and authorization forms sold as a unit	10/23/2008

See all trademarks and details in the Full Report.

Market Share of Bio-Synthesis's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bio-Synthesis, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
OXFORD BIOMEDICA SOLUTIONS	Bedford, MA	100
LAMPIRE BIOLOGICAL LABS	Pipersville, PA	85
MG BIOLOGICS	Ames, IA	39
BIO-SYNTHESIS	Lewisville, TX	37
GREEN MOUNTAIN ANTIBODIES	Burlington, VT	34
TRANS-INDIA PRODUCTS	Santa Rosa, CA	28
PMA MEDIA GROUP	Lehi, UT	25
BAILEY BARK MATERIALS	Nacogdoches, TX	24
1GLOBE HEALTH INSTITUTE	Norwood, MA	23

Nearby Competitors

These companies are similar in business line and location to Bio-Synthesis. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REATA PHARMACEUTICALS	Plano, TX	100
UNITED LABORATORIES MANUFACTURING	Carrollton, TX	73
NEOS THERAPEUTICS	Grand Prairie, TX	24
PREMARK HEALTH SCIENCE	Irving, TX	18
COSMAX NBT USA	Garland, TX	16
BIO-SYNTHESIS	Lewisville, TX	12

Future Competition: Bio-Synthesis's Fastest Growing Competitors

These companies are in the same general field as Bio-Synthesis and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)